Clinical trial

CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)

NCT02047175

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-02-01

PhasePHASE1

Study timeline

Study start (unknown)2014-02-01Date precision: month

Registry last updated2014-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Hyperlipidemiaunresolved

Interventions

Telmisartan/S-AmlodipineDRUG

RosuvastatinDRUG · verified · RxNorm: rosuvastatin

Telmisartan/S-Amlodipine + RosuvastatinDRUG

Sponsors & collaborators

Chong Kun Dang Pharmaceuticallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02047175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.